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Background: Critically ill infants with organ dysfunction are at an increased risk of delirium.
Delirium is defined as an acute and fluctuating change in awareness and cognition in the setting
of medical illness. It is uncommonly recognized in the Neonatal ICU (NICU) and is associated
with several adverse outcomes including increased unplanned extubations, longer duration of
mechanical ventilation and prolonged hospital stays.
Case: A 27-week preterm infant with Bronchopulmonary Dysplasia was discharged home from
the NICU at postmenstrual age (PMA) of 45 weeks on 0.1 LPM 100% FiO2 nasal cannula. The
patient was readmitted at PMA 48 weeks for respiratory distress secondary to
Entero/Rhinovirus bronchiolitis. Six days later the patient continued to have progressive
respiratory failure and was placed on VA ECMO. At that time, the patient was receiving
morphine and midazolam infusions at 0.05 mg/kg/hr and 0.08 mg/kg/hr. On day 4 of ECMO
there was worsening agitation with thrashing, purposeless movements despite multiple
morphine and midazolam boluses. At this time the morphine and midazolam continuous
infusions had been escalated to 0.16 mg/kg/hr and 0.2 mg/kg/hr respectively. The patient was
hyperactive, “combative” and the sedative and analgesic requirement continued to escalate to a
max of 0.24 mg/kg/hr without any improvement in agitation symptoms.
A broad-based work up was initiated to determine the etiology for lack of opioid and
benzodiazepine response. Sepsis evaluation was negative. There was no evidence of hepatic
or renal failure. No acute abnormalities were seen on head ultrasound. Clinical pharmacology
was consulted due to the changes in drug pharmacokinetics on ECMO. After ruling out other

causes, delirium was then considered the most likely cause of these increased movements and
agitation. It was recommended to wean morphine and midazolam aggressively to the lowest
doses possible while maintaining adequate sedation and analgesia. Within 48 hours of rapid
opiate and benzo weaning, significant improvement in symptoms of delirium was seen.
Conclusions: Infant delirium is uncommonly recognized in the NICU. It is a well-known and
prevalent problem in adult and pediatric intensive care units. Possible cause of delirium include
infections, acute electrolyte abnormalities, hepatic or renal failure, drug toxicity or drug
withdrawal. Delirium is a neurobehavioral manifestation of alterations in neurotransmission as
well as alterations in cerebral blood flow, along with disordered cellular homeostasis. The
pharmacokinetics of drugs in infants is rapidly changing with development and the addition of
an ECMO circuit further complicates an estimation of PK. These developmental and circuitrelated pharmacologic changes may increase the risk of delirium in this population. Improved
awareness and monitoring for infant delirium is necessary.

